Related references
Note: Only part of the references are listed.Long term survival in patients with peritoneal metastasised gastric cancer treated with cytoreductive surgery and HIPEC: A multi-institutional cohort from PSOGI
Andreas Brandl et al.
EJSO (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Synchronous Peritoneal Metastases: Multicenter Study of 'Italian Peritoneal Surface Malignancies Oncoteam-SICO'
Luigi Marano et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Long Term Survival after Cytoreductive Surgery Combined with Perioperative Chemotherapy in Gastric Cancer Patients with Peritoneal Metastasis
Yutaka Yonemura et al.
CANCERS (2020)
Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis
Pierre-Emmanuel Bonnot et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
W. J. van Driel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Treatment of patients with peritoneal metastases from gastric cancer
Joji Kitayama et al.
ANNALS OF GASTROENTEROLOGICAL SURGERY (2018)
Outcome Data of Patients with Peritoneal Carcinomatosis from Gastric Origin Treated by a Strategy of Bidirectional Chemotherapy Prior to Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in a Single Specialized Center in Japan
Emel Canbay et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Impact of Maximal Cytoreductive Surgery Plus Regional Heated Intraperitoneal Chemotherapy (HIPEC) on Outcome of Patients With Peritoneal Carcinomatosis of Gastric Origin: Results of the GYMSSA Trial
Udo Rudloff et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
Treatment and prevention of peritoneal carcinomatosis from gastric cancer by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Overview and rationale
F. Roviello et al.
EJSO (2013)
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial
Xiao-Jun Yang et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Peritoneal Carcinomatosis from Gastric Cancer: A Multi-Institutional Study of 159 Patients Treated by Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy
Olivier Glehen et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience
Tristan D. Yan et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Safety and Efficacy of Bidirectional Chemotherapy for Treatment of Patients With Peritoneal Dissemination From Gastric Cancer: Selection for Cytoreductive Surgery
Yutaka Yonemura et al.
JOURNAL OF SURGICAL ONCOLOGY (2009)
Neoadjuvant treatment of gastric cancer with peritoneal dissemination
Y. Yonemura et al.
EJSO (2006)
New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?
PH Sugarbaker
LANCET ONCOLOGY (2006)
Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion
Y Yonemura et al.
BRITISH JOURNAL OF SURGERY (2005)
Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
D Dindo et al.
ANNALS OF SURGERY (2004)
Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer
Y Maehara et al.
BRITISH JOURNAL OF SURGERY (2000)
Share Paper
